Curcumin-loaded lipid and polymeric nanocapsules stabilized by nonionic surfactants: An In Vitro and In Vivo antitumor activity on B16-F10 melanoma and macrophage uptake comparative study

Journal of Biomedical Nanotechnology

Volumn 7, Issue 3, 2011, Pages 406-414

  Mazzarino, Letícia ^a   Silva, Luís F C ^a   Curta, Juliana C ^a   Licínio, Marley A ^a   Costa, Aline ^a   Pacheco, Letícia K ^a   Siqueira, Jarbas M ^a   Montanari, Jorge ^b   Romero, Eder ^b   Assreuy, Jamil ^a   Santos Silva, Maria C ^a   Lemos Senna, Elenara ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

Antitumor activity; B16 F10 melanoma; Curcumin; Cytotoxicity; Lipid nanocapsules; Macrophage uptake; Polymeric nanocapsules

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-TUMOR ACTIVITIES; ANTI-TUMORAL ACTIVITY; B16-F10 MELANOMA; CELL VIABILITY; CLINICAL USE; COMPARATIVE STUDIES; CURCUMA LONGA; CURCUMIN; IN-VITRO; INTRAPERITONEALLY; LIPID NANOCAPSULES; NANOCARRIERS; NANOPRECIPITATION METHOD; PHARMACOLOGICAL ACTIVITY; PHASE INVERSION; POLYPHENOLS; THERAPEUTIC PROPERTIES; TIME-DEPENDENT; TUMOR VOLUMES;

BIOCHEMISTRY; CYTOLOGY; CYTOTOXICITY; DERMATOLOGY; DRUG DOSAGE; FLUORESCENCE MICROSCOPY; MACROPHAGES; NONIONIC SURFACTANTS; ONCOLOGY; POLYMERS;

NANOCAPSULES;

ANTINEOPLASTIC AGENT; CISPLATIN; CURCUMIN; LIPID NANOCAPSULE SUSPENSION; NANOCAPSULE; NONIONIC SURFACTANT; POLYMERIC NANOCAPSULE SUSPENSION; UNCLASSIFIED DRUG; ION; LIPOSOME; SURFACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SCREENING; DRUG UPTAKE; IN VITRO STUDY; MACROPHAGE; MALE; MELANOMA; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG STABILITY; EXPERIMENTAL MELANOMA; IMMUNOLOGY; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CURCUMIN; DRUG STABILITY; IONS; LIPOSOMES; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NANOCAPSULES; PARTICLE SIZE; SURFACE-ACTIVE AGENTS;

EID: 80052312305     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1296     Document Type: Article

References (34)

1. D. R. Siwak, S. Shishodia, B. B. Aggarwal, and R. Kurzrock, Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B-raf/ mitogen/activated/extracellular signal-regulated protein kinase pathway and the akt pathway. Cancer 104, 879 (2005).
2. A. V. Giblin and J. M. Thomas, Incidence, mortality and survival in cutaneous melanoma. J. Plast. Reconstr. Aesthet. Surg. 60, 32 (2007).
3. F. Braud, D. Khayat, B. B. R. Kroon, R. Valdagni, P. Bruzzi, and N. Cascinelli, Malignant melanoma. Crit. Rev. Oncol. Hematol. 47, 35 (2003).
4. C. D. Lao, M. F. Demierre, and V. K. Sondak, Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert. Rev. Anticancer. Ther. 6, 1559 (2006).
5. P. Fresco, F. Borges, C. Diniz, and M. P. Marques, New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747 (2006).
6. M. S. Baliga and S. K. Katiyar, Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci. 5, 243 (2006).
7. B. Aggarwal, A. Kumar, and A. Bharti, Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 23, 363 (2003).
8. R. Thangapazham, A. Sharma, and R. Maheshwari, Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 8, E443 (2006).
9. M. López-Lázaro, Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 52, S103 (2008).
10. L. Menon, R. Kuttan, and G. Kuttan, Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95, 221 (1995).
11. L. Menon, R. Kuttan, and G. Kuttan, Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159 (1999).
12. J. Odot, P. Albert, A. Carlier, M. Tarpin, J. Devy, and C. Madoulet, In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int. J. Cancer 111, 381 (2004).
13. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807 (2007).
14. Y. Wang, M. Pan, A. Cheng, L. Lin, Y. Ho, C. Hsieh, and J. J. Lin, Stability of curcumin in buffer solutions and characterization of its degradation product. J. Pharm. Biomed. Anal. 15, 1867 (1997).
15. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikari, A. Maitra, and A. Maitra, Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): A novel strategy for human cancer therapy. J. Nanobiotechnology 5, 3 (2007).
16. K. Sou, S. Inenaga, S. Takeoka, and E. Tsuchida, Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm. 352, 287 (2008).
17. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337, 299 (2007).
18. A. Sahu, U. Bora, N. Kasoju, and P. Goswami, Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)- palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater. 4, 1752 (2008).
19. D. Wang, M. S. Veena, K. Stevenson, C. Tang, B. Ho, J. D. Suh, V. M. Duarte, K. F. Faull, K. Mehta, E. S. Srivatsan, and M. B. Wang, Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor ΰB by an AKT-independent pathway. Clin. Cancer Res. 14, 6228 (2008).
20. C. Chen, T. D. Johnston, H. Jeon, R. Gedaly, P. P. McHugh, T. G. Burke, and D. Ranjan, An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int. J. Pharm. 366, 133 (2009).
21. V. Mohanraj and Y. Chen, Nanoparticles-A review. Trop. J. Pharm. Res. 5, 561 (2006).
22. V. C. F. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref, D. Labarre, and G. Barratt, Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocápsulas. Biomaterials 22, 2967 (2001).
23. I. Brigger, C. Dubernet, and P. Couvreur, Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631 (2002).
24. L. Mazzarino, C. L. Dora, I. C. Bellettini, E. Minatti, S. G. Cardoso, and E. Lemos-Senna, Curcumin-loaded polymeric and lipid nanocapsules: Preparation, characterization and chemical stability evaluation. Lat. Am. J. Pharm. 29, 933 (2010).
25. F. Lacoeuille, F. Hindre, F. Moal, J. Rpux, C. Passirani, O. Couturier, P. Cales, J. J. L. Jeune, A. Lamprecht, and J. P. Benoit, In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm. 344, 143 (2007).
26. A. Béduneau, P. Saulnier, N. Anton, F. Hindré, C. Passirani, H. Rajerison, N. Noiret, and J. Benoit, Pegylated nanocapsules produced by an organic sovent-free method: Evaluation of their stealth properties. Pharm. Res. 23, 2190 (2006).
27. B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, Process for the preparation of lipid nanocarriers. Pharm. Res. 19, 876 (2002).
28. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial deposition following solvent displacement. Int. J. Pharm. 55, R1 (1989).
29. L. Mazzarino, I. C. Bellettini, E. Minatti, and E. Lemos-Senna, Development and validation of a fluorimetric method to determinecurcumin in lipid and polymeric nanocapsule suspensions. BJPS 46, 219 (2010).
30. A. V. Loosdrecht, R. Beelen, G. Ossenkoppele, M. Broekhoven, and M. Langenhuijsen, A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J. Immunol. Methods 174, 311 (1994).
31. Y. J. Geng, T. Azuma, J. X. Tang, J. H. Hartwig, M. Muszynski, Q. W. P. Libby, and D. J. Kwiatkowski, Caspases-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur. J. Cell Biol. 77, 294 (1998).
32. Y. S. Lee, H. O. Yang, K. H. Shin, H. S. Choi, S. H. Jung, Y. M. Kim, D. K. Oh, R. J. Linhardt, and Y. S. Kim, Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achtina fulica. Eur. J. Pharmacol. 465, 191 (2003).
33. H. H. Tonnesen, M. Másson, and T. Loftsson, Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int. J. Pharm. 244, 127 (2002).
34. G. Loch-Neckel, D. Nemen, A. C. Puhl, D. Fernandes, M. A. Stimamiglio, M. A. Silva, M. Hangai, M. C. S. Silva, and E. Lemos-Senna, Stealth and non-stealth nanocapsules containing camptothecin: In-vitro and in-vivo activity on B16-F10 melanoma. J. Pharm. Pharmac. 59, 1359 (2007).